Showing results (211-220 of 472) with videos related to

Sort By:
Pageof 48
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2014
Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapyClaude Béténé A Dooko, Stephane De Wit, Jacqueline Neuhaus, et al.
Chemical Science|March 6, 2020
Correction: CO<sub>2</sub> induced phase transitions in diamine-appended metal-organic frameworksBess Vlaisavljevich, Sondre K Schnell, Allison L Dzubak, et al.
Physical Review Letters|March 17, 2011
Nonperturbative visualization of nanoscale plasmonic field distributions via photon localization microscopyA McLeod, A Weber-Bargioni, Z Zhang, et al.
Nano Letters|November 27, 2013
Tuning rectification in single-molecular diodesArunabh Batra, Pierre Darancet, Qishui Chen, et al.
Scientific Reports|October 19, 2018
Anisotropic Dirac Fermions in BaMnBi<sub>2</sub> and BaZnBi<sub>2</sub>Hyejin Ryu, Se Young Park, Lijun Li, et al.
Clinical Trials (London, England)|August 24, 2010
Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of HealthJames D Neaton, Abdel Babiker, Mark Bohnhorst, et al.
Angewandte Chemie (International Ed. in English)|August 9, 2018
Small-Band-Gap Halide Double PerovskitesAdam H Slavney, Linn Leppert, Abraham Saldivar Valdes, et al.
Chemical Science|August 2, 2019
Correction: Enhancement of CO<sub>2</sub> binding and mechanical properties upon diamine functionalization of M<sub>2</sub>(dobpdc) metal-organic frameworksJung-Hoon Lee, Rebecca L Siegelman, Lorenzo Maserati, et al.
Circulation|February 1, 1995
Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)P R Liebson, G A Grandits, S Dianzumba, et al.
American Heart Journal|October 1, 1986
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention TrialW B Kannel, J D Neaton, D Wentworth, et al.
Pageof 48